SCHEMBL16009343

SCHEMBL16009343

NC(=O)c1ccccc1C(=O)N(CCCN1CCCC1=O)CCn1c(=O)c(C(=O)NCCCN2CCCC2=O)c(O)c2ncc(Cc3ccc(F)cc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 5/20 0.41
HSD17B10 Q99714 3/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
RXFP1 Q9HBX9 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
FSHR P23945 1/20 0.36
TYRO3 Q06418 1/20 0.36
CASK O14936 1/20 0.35
MERTK Q12866 1/20 0.35
MAPK1 P28482 1/20 0.35
CREBBP Q92793 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5540840 0.88 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5539930 0.86 CYP2C19 (0.46) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5547092 0.86 CYP2C19 (0.46) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL16991717 0.85 KDM4E (0.41) ALDH1A1KDM4EL3MBTL1LMNACREBBP
SCHEMBL5541025 0.85 CYP2C19 (0.45) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5546009 0.85 CYP2C19 (0.46) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL16009342 0.84 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5539125 0.84 CYP2C19 (0.45) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL15163590 0.84 CYP2C19 (0.42) ALDH1A1KDM4EHSD17B10GAAHPGD
SCHEMBL5543248 0.84 CYP2C19 (0.45) ALDH1A1KDM4EHSD17B10GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150225399-A1 HIV INTEGRASE INHIBITORS VIIV HEALTHCARE CO (US) 2015-08-13 US disclosed
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS SHIONOGI & CO., LTD. (JP) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS BCDIN3D, DUT, SAMHD1 ALDH1A1 3812/4885KDM4E 1268/4885HSD17B10 2218/4885
US-20150225399-A1 HIV INTEGRASE INHIBITORS ING2, API5, SAMHD1 ALDH1A1 3073/4885KDM4E 1255/4885HSD17B10 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.